Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02894255

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Teikyo University (from the registry)
Registry
  • NCT NCT02894255
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02894255. Allocation not applicable; no masking; primary purpose treatment. Start 2016-09 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents
Intervention (Device)
Coronary artery bypass grafting
Intervention (Procedure)
Percutaneous coronary intervention
Lead sponsor
Teikyo University (class: other)

Record details

Record id
cardio:ct-nct02894255
Content hash
afeee07238666381071588dce212ae7f0e92351ac637e5bc9f6eee22cedd749e